Table 5. Standard Treatment Options for Burkitt Lymphoma and Diffuse Large B-cell Lymphoma

Trial StratumDisease Manifestations Treatment
COG-C5961 (FAB/LMB-96) [22,27] COG-ANHL01 [31,32]; [24][Level of evidence C1] COG-ANHL1131 (Inter-B-NHL Ritux 2010) [26] ACompletely resected stage I and abdominal stage II Two cycles of chemotherapy [27]
BMultiple extra-abdominal sites Prephase + four cycles of chemotherapy (reduced-intensity arm) [22,34]
Nonresected stage I and II, III (normal LDH)
Stage III (elevated LDH), marrow <25% blasts, no stage IV CNS disease Prephase + four cycles of chemotherapy (reduced-intensity arm) + six doses of rituximab [26]
CMature B-cell ALL (>25% blasts in marrow) and/or stage IV CNS disease Prephase + six cycles of chemotherapy (full-intensity arm) and only two maintenance cycles + six doses of rituximab [26]
GER-GPOH-NHL-BFM-95 [21]R1 Completely resected stage I and abdominal stage IITwo cycles of chemotherapy
R2 Nonresected stage I/II and stage III with LDH <500 IU/LPrephase + four cycles of chemotherapy (4-hour methotrexate infusion)

ALL = acute lymphoblastic leukemia; BFM = Berlin-Frankfurt-Münster; CNS = central nervous system; COG = Children's Oncology Group; FAB = French-American-British; LDH = lactate dehydrogenase; LMB = Lymphome Malins de Burkitt; NHL = non-Hodgkin lymphoma; POG = Pediatric Oncology Group.

From: Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)

Cover of PDQ Cancer Information Summaries
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.